UK markets closed

Altamira Therapeutics Ltd. (CYTO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.4500-0.0300 (-2.03%)
At close: 04:00PM EDT
1.3700 -0.08 (-5.52%)
After hours: 07:38PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2023)Next year (2024)
No. of analysts0011
Avg. Estimate00-4.28-3.04
Low estimate00-4.28-3.04
High estimate00-4.28-3.04
Year ago EPSN/AN/AN/A-4.28
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2023)Next year (2024)
No. of analysts1111
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings historyInvalid DateInvalid DateInvalid DateInvalid Date
Est. EPSN/AN/AN/AN/A
Actual EPSN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2023)Next year (2024)
Current estimate00-4.28-3.04
7 days ago00-4.24-3.01
30 days ago0000
60 days ago0000
90 days ago0000
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCYTOIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current yearN/AN/AN/AN/A
Next year29.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A